![Ralph Charlton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ralph Charlton
Director Técnico/Científico/I+D en
POLARYX THERAPEUTICS, INC.
.
Perfil
Ralph William Charlton is Chief Medical Officer at Polaryx Therapeutics, Inc. since 2026.
Former roles include Executive Medical Director at Allergan, Inc. from 2018 to 2019, Senior Medical Director-Clinical Development at Ascendis Pharma, Inc. from 2019 to 2020, Vice President-Clinical Development at 89bio, Inc. from 2020 to 2022, Chief Medical Officer at Spruce Biosciences, Inc. from 2022 to 2024, and SVP-Clinical Development & Skeletal Dysplasia at Tyra Biosciences, Inc. Education includes undergraduate studies at the University of the Pacific, graduate studies at The University of California, San Francisco, and a doctorate from the Keck School of Medicine of USC.
Cargos activos de Ralph Charlton
| Empresas | Cargo | Inicio |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/09/2026 |
Antiguos cargos conocidos de Ralph Charlton.
| Empresas | Cargo | Fin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 20/12/2024 |
| 89BIO, INC. | Director Técnico/Científico/I+D | 01/02/2022 |
Ascendis Pharma, Inc.
 Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Director Técnico/Científico/I+D | 01/11/2020 |
| ALLERGAN, INC. | Director Técnico/Científico/I+D | 01/05/2019 |
| TYRA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formación de Ralph Charlton.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
26
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck School of Medicine of USC
 Keck School of Medicine of USC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
- Bolsa de valores
- Insiders
- Ralph Charlton
